Free Trial

FY2026 Earnings Forecast for CareCloud Issued By Maxim Group

CareCloud logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Maxim Group raised its FY2026 EPS forecast for CareCloud to $0.35 from $0.33, and projected FY2027 EPS of $0.42.
  • CareCloud reported quarterly EPS of $0.14, beating the $0.10 consensus, while revenue of $33.73 million modestly exceeded estimates of $33.50 million.
  • Analyst views are mixed: MarketBeat lists one Buy and one Hold rating, resulting in an overall “Moderate Buy” consensus.
  • Five stocks to consider instead of CareCloud.

CareCloud, Inc. (NASDAQ:CCLD - Free Report) - Stock analysts at Maxim Group increased their FY2026 earnings estimates for CareCloud in a research note issued on Thursday, November 5th. Maxim Group analyst A. Klee now forecasts that the company will earn $0.35 per share for the year, up from their previous estimate of $0.33. The consensus estimate for CareCloud's current full-year earnings is $0.22 per share. Maxim Group also issued estimates for CareCloud's Q4 2026 earnings at $0.11 EPS, Q1 2027 earnings at $0.05 EPS, Q3 2027 earnings at $0.15 EPS and FY2027 earnings at $0.42 EPS.

CCLD has been the topic of a number of other research reports. Weiss Ratings raised shares of CareCloud from a "hold (c-)" rating to a "hold (c)" rating in a report on Monday, October 12th. Wall Street Zen upgraded shares of CareCloud from a "buy" rating to a "strong-buy" rating in a research report on Saturday. Finally, Roth Capital dropped coverage on CareCloud in a research note on Tuesday, September 15th. They issued a "neutral" rating for the company. Prior estimates, ratings, and price targets should no longer be relied upon. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, CareCloud currently has an average rating of "Moderate Buy".

Read Our Latest Analysis on CCLD

CareCloud Stock Performance

NASDAQ CCLD opened at $2.63 on Wednesday. The company has a quick ratio of 1.01, a current ratio of 1.02 and a debt-to-equity ratio of 2.20. The company has a market capitalization of $111.91 million, a P/E ratio of 20.23 and a beta of 1.57. CareCloud has a 12-month low of $1.67 and a 12-month high of $3.81. The firm has a 50-day moving average price of $2.01 and a two-hundred day moving average price of $2.46.

CareCloud (NASDAQ:CCLD - Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.04. CareCloud had a net margin of 7.36% and a return on equity of 32.32%. The business had revenue of $33.73 million for the quarter, compared to analyst estimates of $33.50 million.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Renaissance Technologies LLC lifted its position in CareCloud by 5.9% during the first quarter. Renaissance Technologies LLC now owns 472,300 shares of the company's stock worth $1,724,000 after purchasing an additional 26,270 shares during the period. Dimensional Fund Advisors LP increased its holdings in CareCloud by 49.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 377,567 shares of the company's stock valued at $1,377,000 after buying an additional 125,435 shares during the period. Globeflex Capital L P acquired a new position in shares of CareCloud in the 2nd quarter valued at approximately $711,000. Arrowstreet Capital Limited Partnership acquired a new position in shares of CareCloud in the 1st quarter valued at approximately $920,000. Finally, BlackRock Inc. acquired a new position in shares of CareCloud in the 2nd quarter valued at approximately $486,000. Institutional investors and hedge funds own 10.16% of the company's stock.

Key Stories Impacting CareCloud

Here are the key news stories impacting CareCloud this week:

  • Positive Sentiment: Maxim Group raised its FY2026 EPS estimate to $0.35 from $0.33 and its FY2027 estimate to $0.42 from $0.40. It also lifted forecasts for Q2 and Q3 2027, suggesting improved expectations for parts of the outlook. CareCloud analyst estimates
  • Positive Sentiment: A separate article highlights dramatically improving margins and the effects of operational and financial restructuring, which could support profitability if sustained. CCLD: Margins improve dramatically; operational and financial restructuring kicks in
  • Neutral Sentiment: Maxim initiated FY2028 projections, including EPS of $0.51, but these are forward estimates rather than a reported result. The reported short-interest figure was zero shares as of November 10, so it does not indicate meaningful short-selling pressure.
  • Negative Sentiment: Maxim lowered its Q4 2026 EPS estimate to $0.11 from $0.15 and its Q1 2027 estimate to $0.05 from $0.06. It also cut its Q4 2027 forecast to $0.10 from $0.12, tempering the more favorable annual and other quarterly revisions.

About CareCloud

(Get Free Report)

CareCloud, Inc. NASDAQ: CCLD provides cloud-based health care information technology and revenue cycle management services to medical practices, hospitals and other health care organizations. The company's solutions are designed to help providers manage administrative, clinical and financial operations through integrated software and technology-enabled services. Its offerings include electronic health records, practice management, medical billing and revenue cycle management, patient engagement tools, telehealth capabilities and related health care technology services.

Read More

Earnings History and Estimates for CareCloud (NASDAQ:CCLD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CareCloud Right Now?

Before you consider CareCloud, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CareCloud wasn't on the list.

While CareCloud currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines